The bidirectional mechanistic links between Alzheimer's disease and cardiovascular disease

Jiaqi You1, Jiawen Yang2

  • 1The First Clinical Medicine School of Guangdong Pharmaceutical University, Guangzhou, China. 2766657782@qq.com.

Insights

Cardiovascular disease (CVD) and Alzheimer's disease (AD) share bidirectional links. Understanding the "cardio-cerebral axis" can improve early risk identification and combined management strategies for these common elderly conditions.

Area of Science:

  • Gerontology
  • Neurology
  • Cardiology

Background:

  • Alzheimer's disease (AD) and cardiovascular disease (CVD) are leading global health concerns in the elderly.
  • Emerging research highlights a significant bidirectional relationship between AD and CVD.
  • This review synthesizes the pathological mechanisms connecting AD and CVD.

Purpose of the Study:

  • To comprehensively review the bidirectional pathological mechanisms linking AD and CVD.
  • To explore the clinical intervention and comorbidity management implications of this relationship.

Main Methods:

  • Systematic review adhering to PRISMA guidelines.
  • Literature search from 1985-2025 across major scientific databases (PubMed, Web of Science, Google Scholar, Embase, Scopus).
  • Analysis of 149 eligible articles after initial screening of 4,434 studies.

Main Results:

  • CVD promotes AD via ischemia-hypoxia, lipid disorders, inflammation, and blood-brain barrier dysfunction.
  • AD increases CVD risk through autonomic dysfunction, central inflammation spillover, lifestyle factors, and drug side effects.
  • Four core pathways identified for CVD influencing AD, and several mechanisms for AD influencing CVD.

Conclusions:

  • AD and CVD are closely interconnected through multiple mechanisms, forming a
  • cardio-cerebral axis.
  • Understanding this axis aids in early risk detection for comorbid populations.
  • This knowledge can guide combined management strategies for AD and CVD in clinical practice.
Abstract

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...